Eris Lifesciences financials at a glance

+ Portfolio

The revenue of Eris Lifesciences is reported as 16.85149 billion Rupees in the fiscal year 2024. The earnings were 28.07 Rupees per share in 2024, which was 6.06 lower than 2022. And about 2.91738 billion Rupees are reported as free cash flow in the financials of Eris Lifesciences 2024. Dividends of 7.35 Rupees per share were paid to shareholders of Eris Lifesciences stock NSEI:ERIS in fiscal 2024.

Rp16.85B

Revenue

Rp28.07

Earnings Per Share

78.26%

Gross Margin %

Rp-5,496.83M

Free Cash Flow

Revenue

16,851.49

Earnings Per Share

28.07

Gross Margin %

78.26

Free Cash Flow

-5,496.83

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017
Rev.	Revenue	N/A	Rp16.85B	Rp13.47B	Rp12.12B	Rp10.74B	Rp9.82B	Rp8.82B	Rp0.00M
GM %	Gross Margin %	80.65%	78.26%	80.51%	79.71%	83.44%	83.70%	84.19%	0.00%
OM	Operating Margin	25.97%	25.37%	31.69%	32.50%	30.42%	31.94%	36.60%	0.00%
EPS	Earnings Per Share	Rp28.31	Rp28.07	Rp29.88	Rp26.14	Rp21.58	Rp21.13	Rp21.39	Rp17.61
Div.	Dividends	N/A	Rp7.35	Rp6.01	Rp5.50	Rp2.29	Rp0.00	Rp0.00	Rp0.00
PR %	Payout Ratio %	0	26.18%	20.11%	21.04%	10.61%	0.00%	0.00%	0
Sha.	Shares	N/AM	135.99M	135.93M	135.78M	135.78M	137.52M	137.5M	137.5M
OCF	Operating Cash Flow	N/A	Rp2.92B	Rp3.78B	Rp3.75B	Rp2.72B	Rp2.23B	Rp2.35B	Rp0.00M
FCF	Free Cash Flow	N/A	Rp-5,496.83M	Rp2.57B	Rp3.50B	Rp1.20B	Rp1.85B	Rp-3,148.30M	Rp0.00M
FCFS	Free Cash Flow Per Share	Rp-24.28	Rp-40.42	Rp18.93	Rp25.75	Rp8.73	Rp13.45	Rp15.24	Rp0.00

Eris Lifesciences financials at a glance

Financials

Discover